Today, Paradigm Health announced the launch of a landmark research collaboration with the U.S. Food & Drug Administration (FDA) focused on advancing a new model to accelerate clinical trial execution ...
External development and manufacturing is an important part of pharmaceutical companies’ strategies and directly affects the business models adopted by contract service providers in meeting those ...
Takeda Pharmaceutical to Acquire Paradigm Therapeutics Limited OSAKA, Japan & CAMBRIDGE, England -- Takeda Pharmaceutical Company Limited ("Takeda") today announced that Takeda and Paradigm ...
Pharmaceutical companies are seeing the development process in a new way, and that has major implications for service providers. The effort to improve the effectiveness of research and development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results